메뉴 건너뛰기
Gene Therapy
Volumn 15, Issue 15, 2008, Pages 1077-1078
Treatments for muscular dystrophy: Increased treatment options for Duchenne and related muscular dystropies
Author keywords

[No Author keywords available]
Indexed keywords

ALPHA7 INTEGRIN; CYCLOPHILIN D; DEBIO 025; DYSTROPHIN; ISOMERASE INHIBITOR; LOSARTAN; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UTROPHIN;
EID: 47549101810     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2008.97     Document Type: Note
Times cited : (5)
References (7)
  • 1
    • 41849118741 scopus 로고    scopus 로고
    • Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy
    • Millay DP, Sargent MA, Osinska H, Baines CP, Barton ER, Vuagniaux G et al. Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat Med 2008; 14: 442-447.
    • (2008) Nat Med , vol.14 , pp. 442-447
    • Millay, D.P.1    Sargent, M.A.2    Osinska, H.3    Baines, C.P.4    Barton, E.R.5    Vuagniaux, G.6
  • 2
    • 33846384302 scopus 로고    scopus 로고
    • Genetic modifiers of muscular dystrophy: Implications for therapy
    • Heydemann A, Doherty KR, McNally EM. Genetic modifiers of muscular dystrophy: Implications for therapy. Biochim Biophys Acta 2007; 1772: 216-228.
    • (2007) Biochim Biophys Acta , vol.1772 , pp. 216-228
    • Heydemann, A.1    Doherty, K.R.2    McNally, E.M.3
  • 3
    • 36249019783 scopus 로고    scopus 로고
    • New therapies for Duchenne muscular dystrophy: Challenges, prospects and clinical trials
    • Cossu G, Sampaolesi M. New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials. Trends Mol Med 2007; 13: 520-526.
    • (2007) Trends Mol Med , vol.13 , pp. 520-526
    • Cossu, G.1    Sampaolesi, M.2
  • 4
    • 34648854432 scopus 로고    scopus 로고
    • Genetic treatments in muscular dystrophy
    • Muntoni F, Wells D. Genetic treatments in muscular dystrophy. Curr Opin Neurol 2007; 20: 590-594.
    • (2007) Curr Opin Neurol , vol.20 , pp. 590-594
    • Muntoni, F.1    Wells, D.2
  • 5
    • 33846946114 scopus 로고    scopus 로고
    • Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states
    • Cohn RD, van Erp C, Habashi JP, Soleimani AA, Klein EC, Lisi MT et al Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat Med 2007; 13: 204-210.
    • (2007) Nat Med , vol.13 , pp. 204-210
    • Cohn, R.D.1    van Erp, C.2    Habashi, J.P.3    Soleimani, A.A.4    Klein, E.C.5    Lisi, M.T.6
  • 6
    • 33846194248 scopus 로고    scopus 로고
    • Duchenne muscular dystrophy: Focus on pharmaceutical and nutritional interventions
    • Radley HG, De Luca A, Lynch GS, Grounds MD. Duchenne muscular dystrophy: focus on pharmaceutical and nutritional interventions. Int J Biochem Cell Biol 2007; 39: 469-477.
    • (2007) Int J Biochem Cell Biol , vol.39 , pp. 469-477
    • Radley, H.G.1    De Luca, A.2    Lynch, G.S.3    Grounds, M.D.4
  • 7
    • 15844375853 scopus 로고    scopus 로고
    • Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death
    • Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005; 434: 658-662.
    • (2005) Nature , vol.434 , pp. 658-662
    • Baines, C.P.1    Kaiser, R.A.2    Purcell, N.H.3    Blair, N.S.4    Osinska, H.5    Hambleton, M.A.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.